A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers

Clinical trial NCT07539415 · RECRUITING

Trial details

NCT number: NCT07539415
Sponsor: Daewoong Pharmaceutical Co. LTD.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Obesity & Overweight Type 2 Diabetes

Start date: 2026-05-06
Primary completion: 2026-10-27
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.